Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).

被引：1
|
作者：
Kim, Se Eun
Cole, Suzanne
Wulff-Burchfield, Elizabeth Marie
Wentland, Andrew
Hannan, Mu-Han
Kapur, Payal
Shevrin, Daniel
Gurley, Tami
Lin, John Kent
Brugarolas, James
Timmerman, Robert D.
Mckay, Rana R.
Wagner, Lynne I.
Haas, Naomi B.
Carducci, Michael Anthony
机构：
[1] Univ Texas Southwestern Med Ctr, Dallas, TX USA
[2] DFCI PCC Fellowship Program Attendings, Boston, MA USA
[3] Univ Kansas, Med Ctr, Westwood, KS USA
[4] Univ Wisconsin, Madison, WI USA
[5] Univ Texas Southwestern, Dept Pathol, Dallas, TX USA
[6] Northshore Univ Hlth Syst, Evanston, IL USA
[7] UT Southwestern Med Ctr, Dallas, TX USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[9] Univ Texas Southwestern, Div Hematol & Oncol, Dept Internal Med, Dallas, TX USA
[10] Univ Texas Southwestern Med Ctr, Radiat Oncol, Dallas, TX USA
[11] Univ Calif San Diego, La Jolla, CA USA
[12] Wake Forest Univ, Sch Med, Winston Salem, NC USA
[13] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
261-566-11347; 261-137-3222-3876-5567; 283-424-3231; 261-492-3532-2370-7650-2700; 3282-270-434-2806; 261-492-199; 261-137; 11; 10; 6; 5; 4;
D O I：
10.1200/JCO.2024.42.4_suppl.TPS489
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：TPS489 / TPS489
页数：1
相关论文
共 50 条
  • [21] Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR): Overall Survival Results of the SABR-5 Trial
    Jiang, W. N.
    Baker, S.
    Liu, M.
    Bergman, A.
    Schellenberg, D.
    Mou, B.
    Alexander, A. S.
    Carolan, H.
    Atrchian, S.
    Chan, E. K.
    Mohamed, I. G.
    Berrang, T.
    Bang, A.
    Chng, N.
    Matthews, Q.
    Pai, H. H.
    Lefresne, S.
    Tyldesley, S.
    Olson, R. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S147 - S148
  • [22] A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol
    Palma, David A.
    Giuliani, Meredith E.
    Correa, Rohann J. M.
    Schneiders, Famke L.
    Harrow, Stephen
    Guckenberger, Matthias
    Zhang, Tina
    Bahig, Houda
    Senthi, Sashendra
    Chung, Peter
    Olson, Robert
    Lock, Michael
    Raman, Srinivas
    Bauman, Glenn S.
    Lok, Benjamin H.
    Laba, Joanna M.
    Glicksman, Rachel M.
    Nguyen, Timothy K.
    Lang, Pencilla
    Helou, Joelle
    Goodman, Christopher D.
    Mendez, Lucas C.
    van Rossum, Peter S. N.
    Warner, Andrew
    Gaede, Stewart
    Allan, Alison L.
    BMC PALLIATIVE CARE, 2024, 23 (01):
  • [23] The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease
    Marandino, Laura
    Ciccarese, Chiara
    Francolini, Giulio
    Amparore, Daniele
    Campi, Riccardo
    MINERVA UROLOGY AND NEPHROLOGY, 2023, 75 (02): : 260 - 264
  • [24] An Interim Safety Analysis of Combination Stereotactic Ablative Body Radiotherapy (SABR) with Adjuvant Anti-PD1 Immunotherapy in Oligometastatic Renal Cell Carcinoma
    Siva, Shankar
    Bressel, Mathias
    Sandhu, Shahneen
    Tran, Ben
    Mooi, Jennifer
    Lewin, Jeremy
    Loi, Sherene
    Toner, Guy
    Moon, Daniel
    Goad, Jeremy
    Shaw, Mark
    Chander, Sarat
    Eade, Thomas
    Guminksi, Alex
    Dasantha, Jayamanne
    Pryor, David
    Cuff, Katherine
    Wood, Simon
    Lawrentschuk, Nathan
    Murphy, Declan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 31 - 31
  • [25] Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Renal Cancer
    Hannan, Raquibul
    McLaughlin, Mark F.
    Pop, Laurentiu M.
    Pedrosa, Ivan
    Kapur, Payal
    Garant, Aurelie
    Ahn, Chul
    Christie, Alana
    Zhu, James
    Wangg, Tao
    Robles, Liliana
    Durakoglugil, Deniz
    Woldu, Solomon
    Margulis, Vitaly
    Gahan, Jeffrey
    Brugarolas, James
    Timmerman, Robert
    Cadeddu, Jeffrey
    EUROPEAN UROLOGY, 2023, 84 (03) : 275 - 286
  • [26] Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies
    Zaorsky, Nicholas G.
    Lehrer, Eric J.
    Kothari, Gargi
    Louie, Alexander, V
    Siva, Shankar
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (05): : 515 - 523
  • [27] Evaluation of Volumetric Response Assessment from Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Carcinoma (RCC)
    Schep, D.
    Dayes, I.
    Lukka, H.
    Quan, K.
    Kapoor, A.
    Vansantvoort, J.
    Chow, T.
    Swaminath, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E434 - E434
  • [28] EVALUATION OF VOLUMETRIC RESPONSE ASSESSMENT FROM STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR RENAL CELL CARCINOMA (RCC)
    Schep, Daniel
    Dayes, Ian
    Lukka, Himanshu
    Quan, Kimmen
    Kapoor, Anil
    Vansantvoort, Jasmin
    Chow, Tom
    Swaminath, Anand
    RADIOTHERAPY AND ONCOLOGY, 2023, 186 : S67 - S67
  • [29] Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Secondary Analysis of the Phase II SABR-5 Trial
    Kooyman, A.
    Chang, J. S.
    Liu, M.
    Jiang, W.
    Bergman, A.
    Schellenberg, D.
    Mou, B.
    Alexander, A. S.
    Carolan, H.
    Hsu, F.
    Atrchian, S.
    Chan, E. K.
    Berrang, T.
    Chng, N.
    Matthews, Q.
    Pai, H. H.
    Valev, B.
    Tyldesley, S.
    Olson, R. A.
    Baker, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S26 - S26
  • [30] EVALUATING TOXICITY AND INTERACTION OUTCOMES OF SYSTEMIC THERAPY AND STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTATIC DISEASE: A SECONDARY ANALYSIS OF THE PHASE II SABR-5 TRIAL
    Kooyman, Aiden
    Chang, Jee Suk
    Liu, Mitchell
    Jiang, Will
    Bergman, Alanah
    Schellenberg, Devin
    Mou, Benjamin
    Alexander, Abraham
    Carolan, Hannah
    Hsu, Fred
    Miller, Stacy
    Atrchian, Siavash
    Chan, Elisa
    Ho, Clement
    Mohamed, Islam
    Lin, Angela
    Berrang, Tanya
    Bang, Andrew
    Chng, Nick
    Matthews, Quinn
    Huang, Vicky
    Mestrovic, Ante
    Hyde, Derek
    Lund, Chad
    Pai, Howard
    Valev, Boris
    LeFresne, Shilo
    Tyldesley, Scott
    Olson, Robert
    Baker, Sarah
    RADIOTHERAPY AND ONCOLOGY, 2024, 198 : S36 - S36
12345